nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2C19—Cholecalciferol—osteoporosis	0.0733	0.143	CbGbCtD
Felbamate—CYP3A4—Estropipate—osteoporosis	0.0688	0.134	CbGbCtD
Felbamate—CYP3A4—Calcitriol—osteoporosis	0.0688	0.134	CbGbCtD
Felbamate—CYP2C19—Estradiol—osteoporosis	0.0591	0.115	CbGbCtD
Felbamate—CYP3A4—Ergocalciferol—osteoporosis	0.055	0.107	CbGbCtD
Felbamate—CYP3A4—Raloxifene—osteoporosis	0.0459	0.0897	CbGbCtD
Felbamate—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0444	0.0866	CbGbCtD
Felbamate—CYP3A4—Cholecalciferol—osteoporosis	0.0355	0.0692	CbGbCtD
Felbamate—CYP3A4—Conjugated Estrogens—osteoporosis	0.0326	0.0636	CbGbCtD
Felbamate—CYP3A4—Estradiol—osteoporosis	0.0286	0.0558	CbGbCtD
Felbamate—Lacosamide—CA2—osteoporosis	0.00241	1	CrCbGaD
Felbamate—Infection—Pamidronate—osteoporosis	0.00037	0.000765	CcSEcCtD
Felbamate—Rhinitis—Estradiol—osteoporosis	0.00037	0.000765	CcSEcCtD
Felbamate—Urticaria—Calcitriol—osteoporosis	0.000369	0.000765	CcSEcCtD
Felbamate—Hepatitis—Estradiol—osteoporosis	0.000369	0.000763	CcSEcCtD
Felbamate—Haemorrhage—Estradiol—osteoporosis	0.000369	0.000763	CcSEcCtD
Felbamate—Palpitations—Zoledronate—osteoporosis	0.000368	0.000762	CcSEcCtD
Felbamate—Body temperature increased—Calcitriol—osteoporosis	0.000368	0.000761	CcSEcCtD
Felbamate—Abdominal pain—Calcitriol—osteoporosis	0.000368	0.000761	CcSEcCtD
Felbamate—Pharyngitis—Estradiol—osteoporosis	0.000366	0.000758	CcSEcCtD
Felbamate—Thrombocytopenia—Pamidronate—osteoporosis	0.000364	0.000754	CcSEcCtD
Felbamate—Vomiting—Etidronic acid—osteoporosis	0.000364	0.000754	CcSEcCtD
Felbamate—Cough—Zoledronate—osteoporosis	0.000363	0.000752	CcSEcCtD
Felbamate—Tachycardia—Pamidronate—osteoporosis	0.000363	0.000752	CcSEcCtD
Felbamate—Rash—Etidronic acid—osteoporosis	0.000361	0.000747	CcSEcCtD
Felbamate—Dermatitis—Etidronic acid—osteoporosis	0.000361	0.000747	CcSEcCtD
Felbamate—Hyperhidrosis—Pamidronate—osteoporosis	0.00036	0.000745	CcSEcCtD
Felbamate—Hypertension—Zoledronate—osteoporosis	0.00036	0.000744	CcSEcCtD
Felbamate—Headache—Etidronic acid—osteoporosis	0.000359	0.000743	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000357	0.000738	CcSEcCtD
Felbamate—Asthenia—Estropipate—osteoporosis	0.000355	0.000736	CcSEcCtD
Felbamate—Visual impairment—Estradiol—osteoporosis	0.000355	0.000736	CcSEcCtD
Felbamate—Anorexia—Pamidronate—osteoporosis	0.000355	0.000734	CcSEcCtD
Felbamate—Arthralgia—Zoledronate—osteoporosis	0.000355	0.000734	CcSEcCtD
Felbamate—Myalgia—Zoledronate—osteoporosis	0.000355	0.000734	CcSEcCtD
Felbamate—Chest pain—Zoledronate—osteoporosis	0.000355	0.000734	CcSEcCtD
Felbamate—Palpitations—Conjugated Estrogens—osteoporosis	0.000354	0.000734	CcSEcCtD
Felbamate—Insomnia—Risedronate—osteoporosis	0.000354	0.000733	CcSEcCtD
Felbamate—Anxiety—Zoledronate—osteoporosis	0.000353	0.000732	CcSEcCtD
Felbamate—Paraesthesia—Risedronate—osteoporosis	0.000352	0.000728	CcSEcCtD
Felbamate—Pruritus—Estropipate—osteoporosis	0.00035	0.000725	CcSEcCtD
Felbamate—Discomfort—Zoledronate—osteoporosis	0.00035	0.000725	CcSEcCtD
Felbamate—Asthenia—Alendronate—osteoporosis	0.00035	0.000725	CcSEcCtD
Felbamate—Cough—Conjugated Estrogens—osteoporosis	0.00035	0.000724	CcSEcCtD
Felbamate—Dyspnoea—Risedronate—osteoporosis	0.000349	0.000722	CcSEcCtD
Felbamate—Erythema multiforme—Estradiol—osteoporosis	0.000349	0.000722	CcSEcCtD
Felbamate—Hypotension—Pamidronate—osteoporosis	0.000348	0.00072	CcSEcCtD
Felbamate—Dry mouth—Zoledronate—osteoporosis	0.000347	0.000718	CcSEcCtD
Felbamate—Fatigue—Ethinyl Estradiol—osteoporosis	0.000346	0.000717	CcSEcCtD
Felbamate—Pruritus—Alendronate—osteoporosis	0.000345	0.000715	CcSEcCtD
Felbamate—Dyspepsia—Risedronate—osteoporosis	0.000345	0.000713	CcSEcCtD
Felbamate—Constipation—Ethinyl Estradiol—osteoporosis	0.000343	0.000711	CcSEcCtD
Felbamate—Confusional state—Zoledronate—osteoporosis	0.000343	0.00071	CcSEcCtD
Felbamate—Flushing—Estradiol—osteoporosis	0.000342	0.000708	CcSEcCtD
Felbamate—Chest pain—Conjugated Estrogens—osteoporosis	0.000341	0.000707	CcSEcCtD
Felbamate—Myalgia—Conjugated Estrogens—osteoporosis	0.000341	0.000707	CcSEcCtD
Felbamate—Arthralgia—Conjugated Estrogens—osteoporosis	0.000341	0.000707	CcSEcCtD
Felbamate—Asthenia—Ibandronate—osteoporosis	0.000341	0.000706	CcSEcCtD
Felbamate—Anxiety—Conjugated Estrogens—osteoporosis	0.00034	0.000704	CcSEcCtD
Felbamate—Nausea—Etidronic acid—osteoporosis	0.00034	0.000704	CcSEcCtD
Felbamate—Anaphylactic shock—Zoledronate—osteoporosis	0.00034	0.000704	CcSEcCtD
Felbamate—Oedema—Zoledronate—osteoporosis	0.00034	0.000704	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000339	0.000702	CcSEcCtD
Felbamate—Diarrhoea—Estropipate—osteoporosis	0.000339	0.000702	CcSEcCtD
Felbamate—Infection—Zoledronate—osteoporosis	0.000338	0.000699	CcSEcCtD
Felbamate—Fatigue—Risedronate—osteoporosis	0.000338	0.000699	CcSEcCtD
Felbamate—Insomnia—Pamidronate—osteoporosis	0.000337	0.000697	CcSEcCtD
Felbamate—Pruritus—Ibandronate—osteoporosis	0.000336	0.000696	CcSEcCtD
Felbamate—Constipation—Risedronate—osteoporosis	0.000335	0.000693	CcSEcCtD
Felbamate—Pain—Risedronate—osteoporosis	0.000335	0.000693	CcSEcCtD
Felbamate—Paraesthesia—Pamidronate—osteoporosis	0.000334	0.000692	CcSEcCtD
Felbamate—Diarrhoea—Alendronate—osteoporosis	0.000334	0.000691	CcSEcCtD
Felbamate—Asthenia—Calcitriol—osteoporosis	0.000334	0.000691	CcSEcCtD
Felbamate—Thrombocytopenia—Zoledronate—osteoporosis	0.000333	0.000689	CcSEcCtD
Felbamate—Dyspnoea—Pamidronate—osteoporosis	0.000332	0.000687	CcSEcCtD
Felbamate—Tachycardia—Zoledronate—osteoporosis	0.000332	0.000687	CcSEcCtD
Felbamate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000331	0.000685	CcSEcCtD
Felbamate—Chills—Estradiol—osteoporosis	0.000331	0.000685	CcSEcCtD
Felbamate—Somnolence—Pamidronate—osteoporosis	0.000331	0.000685	CcSEcCtD
Felbamate—Pruritus—Calcitriol—osteoporosis	0.000329	0.000681	CcSEcCtD
Felbamate—Hyperhidrosis—Zoledronate—osteoporosis	0.000329	0.00068	CcSEcCtD
Felbamate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000328	0.00068	CcSEcCtD
Felbamate—Diarrhoea—Raloxifene—osteoporosis	0.000328	0.00068	CcSEcCtD
Felbamate—Dyspepsia—Pamidronate—osteoporosis	0.000328	0.000678	CcSEcCtD
Felbamate—Dizziness—Estropipate—osteoporosis	0.000328	0.000678	CcSEcCtD
Felbamate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000327	0.000678	CcSEcCtD
Felbamate—Oedema—Conjugated Estrogens—osteoporosis	0.000327	0.000678	CcSEcCtD
Felbamate—Alopecia—Estradiol—osteoporosis	0.000326	0.000674	CcSEcCtD
Felbamate—Infection—Conjugated Estrogens—osteoporosis	0.000325	0.000673	CcSEcCtD
Felbamate—Diarrhoea—Ibandronate—osteoporosis	0.000325	0.000673	CcSEcCtD
Felbamate—Anorexia—Zoledronate—osteoporosis	0.000324	0.000671	CcSEcCtD
Felbamate—Decreased appetite—Pamidronate—osteoporosis	0.000324	0.00067	CcSEcCtD
Felbamate—Dizziness—Alendronate—osteoporosis	0.000323	0.000668	CcSEcCtD
Felbamate—Fatigue—Pamidronate—osteoporosis	0.000321	0.000664	CcSEcCtD
Felbamate—Gastrointestinal pain—Risedronate—osteoporosis	0.00032	0.000663	CcSEcCtD
Felbamate—Tachycardia—Conjugated Estrogens—osteoporosis	0.000319	0.000661	CcSEcCtD
Felbamate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000319	0.00066	CcSEcCtD
Felbamate—Pain—Pamidronate—osteoporosis	0.000318	0.000659	CcSEcCtD
Felbamate—Constipation—Pamidronate—osteoporosis	0.000318	0.000659	CcSEcCtD
Felbamate—Diarrhoea—Calcitriol—osteoporosis	0.000318	0.000659	CcSEcCtD
Felbamate—Hypotension—Zoledronate—osteoporosis	0.000318	0.000658	CcSEcCtD
Felbamate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000317	0.000657	CcSEcCtD
Felbamate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000317	0.000657	CcSEcCtD
Felbamate—Dizziness—Raloxifene—osteoporosis	0.000317	0.000657	CcSEcCtD
Felbamate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000316	0.000655	CcSEcCtD
Felbamate—Flatulence—Estradiol—osteoporosis	0.000316	0.000655	CcSEcCtD
Felbamate—Tension—Estradiol—osteoporosis	0.000315	0.000652	CcSEcCtD
Felbamate—Vomiting—Estropipate—osteoporosis	0.000315	0.000652	CcSEcCtD
Felbamate—Dysgeusia—Estradiol—osteoporosis	0.000314	0.000651	CcSEcCtD
Felbamate—Dizziness—Ibandronate—osteoporosis	0.000314	0.00065	CcSEcCtD
Felbamate—Rash—Estropipate—osteoporosis	0.000312	0.000647	CcSEcCtD
Felbamate—Dermatitis—Estropipate—osteoporosis	0.000312	0.000646	CcSEcCtD
Felbamate—Anorexia—Conjugated Estrogens—osteoporosis	0.000312	0.000646	CcSEcCtD
Felbamate—Nervousness—Estradiol—osteoporosis	0.000312	0.000645	CcSEcCtD
Felbamate—Urticaria—Risedronate—osteoporosis	0.000311	0.000644	CcSEcCtD
Felbamate—Headache—Estropipate—osteoporosis	0.00031	0.000642	CcSEcCtD
Felbamate—Vomiting—Alendronate—osteoporosis	0.00031	0.000642	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00031	0.000641	CcSEcCtD
Felbamate—Abdominal pain—Risedronate—osteoporosis	0.000309	0.000641	CcSEcCtD
Felbamate—Body temperature increased—Risedronate—osteoporosis	0.000309	0.000641	CcSEcCtD
Felbamate—Rash—Alendronate—osteoporosis	0.000308	0.000637	CcSEcCtD
Felbamate—Insomnia—Zoledronate—osteoporosis	0.000307	0.000636	CcSEcCtD
Felbamate—Dermatitis—Alendronate—osteoporosis	0.000307	0.000636	CcSEcCtD
Felbamate—Feeling abnormal—Pamidronate—osteoporosis	0.000307	0.000635	CcSEcCtD
Felbamate—Hypotension—Conjugated Estrogens—osteoporosis	0.000306	0.000633	CcSEcCtD
Felbamate—Headache—Alendronate—osteoporosis	0.000306	0.000633	CcSEcCtD
Felbamate—Paraesthesia—Zoledronate—osteoporosis	0.000305	0.000632	CcSEcCtD
Felbamate—Vomiting—Raloxifene—osteoporosis	0.000305	0.000632	CcSEcCtD
Felbamate—Gastrointestinal pain—Pamidronate—osteoporosis	0.000304	0.00063	CcSEcCtD
Felbamate—Dyspnoea—Zoledronate—osteoporosis	0.000303	0.000627	CcSEcCtD
Felbamate—Rash—Raloxifene—osteoporosis	0.000303	0.000626	CcSEcCtD
Felbamate—Dermatitis—Raloxifene—osteoporosis	0.000302	0.000626	CcSEcCtD
Felbamate—Somnolence—Zoledronate—osteoporosis	0.000302	0.000626	CcSEcCtD
Felbamate—Vomiting—Ibandronate—osteoporosis	0.000302	0.000625	CcSEcCtD
Felbamate—Tremor—Estradiol—osteoporosis	0.000301	0.000623	CcSEcCtD
Felbamate—Headache—Raloxifene—osteoporosis	0.000301	0.000622	CcSEcCtD
Felbamate—Rash—Ibandronate—osteoporosis	0.0003	0.00062	CcSEcCtD
Felbamate—Dermatitis—Ibandronate—osteoporosis	0.000299	0.000619	CcSEcCtD
Felbamate—Dyspepsia—Zoledronate—osteoporosis	0.000299	0.000619	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000298	0.000617	CcSEcCtD
Felbamate—Ill-defined disorder—Estradiol—osteoporosis	0.000298	0.000617	CcSEcCtD
Felbamate—Headache—Ibandronate—osteoporosis	0.000298	0.000616	CcSEcCtD
Felbamate—Insomnia—Conjugated Estrogens—osteoporosis	0.000296	0.000613	CcSEcCtD
Felbamate—Vomiting—Calcitriol—osteoporosis	0.000296	0.000612	CcSEcCtD
Felbamate—Decreased appetite—Zoledronate—osteoporosis	0.000295	0.000612	CcSEcCtD
Felbamate—Agitation—Estradiol—osteoporosis	0.000295	0.000611	CcSEcCtD
Felbamate—Nausea—Estropipate—osteoporosis	0.000294	0.000609	CcSEcCtD
Felbamate—Abdominal pain—Pamidronate—osteoporosis	0.000294	0.000609	CcSEcCtD
Felbamate—Body temperature increased—Pamidronate—osteoporosis	0.000294	0.000609	CcSEcCtD
Felbamate—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000294	0.000608	CcSEcCtD
Felbamate—Rash—Calcitriol—osteoporosis	0.000293	0.000607	CcSEcCtD
Felbamate—Fatigue—Zoledronate—osteoporosis	0.000293	0.000607	CcSEcCtD
Felbamate—Dermatitis—Calcitriol—osteoporosis	0.000293	0.000606	CcSEcCtD
Felbamate—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000292	0.000604	CcSEcCtD
Felbamate—Headache—Calcitriol—osteoporosis	0.000291	0.000603	CcSEcCtD
Felbamate—Somnolence—Conjugated Estrogens—osteoporosis	0.000291	0.000602	CcSEcCtD
Felbamate—Constipation—Zoledronate—osteoporosis	0.000291	0.000602	CcSEcCtD
Felbamate—Pain—Zoledronate—osteoporosis	0.000291	0.000602	CcSEcCtD
Felbamate—Nausea—Alendronate—osteoporosis	0.00029	0.0006	CcSEcCtD
Felbamate—Malaise—Estradiol—osteoporosis	0.000289	0.000599	CcSEcCtD
Felbamate—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000288	0.000596	CcSEcCtD
Felbamate—Asthenia—Ethinyl Estradiol—osteoporosis	0.000288	0.000596	CcSEcCtD
Felbamate—Nausea—Raloxifene—osteoporosis	0.000285	0.00059	CcSEcCtD
Felbamate—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000285	0.000589	CcSEcCtD
Felbamate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000284	0.000588	CcSEcCtD
Felbamate—Palpitations—Estradiol—osteoporosis	0.000284	0.000587	CcSEcCtD
Felbamate—Fatigue—Conjugated Estrogens—osteoporosis	0.000282	0.000584	CcSEcCtD
Felbamate—Nausea—Ibandronate—osteoporosis	0.000282	0.000584	CcSEcCtD
Felbamate—Asthenia—Risedronate—osteoporosis	0.000281	0.000581	CcSEcCtD
Felbamate—Feeling abnormal—Zoledronate—osteoporosis	0.00028	0.00058	CcSEcCtD
Felbamate—Cough—Estradiol—osteoporosis	0.00028	0.00058	CcSEcCtD
Felbamate—Pain—Conjugated Estrogens—osteoporosis	0.00028	0.000579	CcSEcCtD
Felbamate—Constipation—Conjugated Estrogens—osteoporosis	0.00028	0.000579	CcSEcCtD
Felbamate—Gastrointestinal pain—Zoledronate—osteoporosis	0.000278	0.000575	CcSEcCtD
Felbamate—Hypertension—Estradiol—osteoporosis	0.000277	0.000574	CcSEcCtD
Felbamate—Pruritus—Risedronate—osteoporosis	0.000277	0.000573	CcSEcCtD
Felbamate—Nausea—Calcitriol—osteoporosis	0.000276	0.000572	CcSEcCtD
Felbamate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000275	0.000569	CcSEcCtD
Felbamate—Arthralgia—Estradiol—osteoporosis	0.000273	0.000566	CcSEcCtD
Felbamate—Chest pain—Estradiol—osteoporosis	0.000273	0.000566	CcSEcCtD
Felbamate—Myalgia—Estradiol—osteoporosis	0.000273	0.000566	CcSEcCtD
Felbamate—Anxiety—Estradiol—osteoporosis	0.000272	0.000564	CcSEcCtD
Felbamate—Urticaria—Zoledronate—osteoporosis	0.00027	0.000559	CcSEcCtD
Felbamate—Discomfort—Estradiol—osteoporosis	0.00027	0.000559	CcSEcCtD
Felbamate—Abdominal pain—Zoledronate—osteoporosis	0.000269	0.000556	CcSEcCtD
Felbamate—Body temperature increased—Zoledronate—osteoporosis	0.000269	0.000556	CcSEcCtD
Felbamate—Diarrhoea—Risedronate—osteoporosis	0.000268	0.000554	CcSEcCtD
Felbamate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000268	0.000554	CcSEcCtD
Felbamate—Dry mouth—Estradiol—osteoporosis	0.000267	0.000553	CcSEcCtD
Felbamate—Asthenia—Pamidronate—osteoporosis	0.000267	0.000553	CcSEcCtD
Felbamate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000266	0.00055	CcSEcCtD
Felbamate—Confusional state—Estradiol—osteoporosis	0.000264	0.000547	CcSEcCtD
Felbamate—Pruritus—Pamidronate—osteoporosis	0.000263	0.000545	CcSEcCtD
Felbamate—Oedema—Estradiol—osteoporosis	0.000262	0.000542	CcSEcCtD
Felbamate—Anaphylactic shock—Estradiol—osteoporosis	0.000262	0.000542	CcSEcCtD
Felbamate—Infection—Estradiol—osteoporosis	0.00026	0.000539	CcSEcCtD
Felbamate—Urticaria—Conjugated Estrogens—osteoporosis	0.00026	0.000538	CcSEcCtD
Felbamate—Dizziness—Risedronate—osteoporosis	0.000259	0.000536	CcSEcCtD
Felbamate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000259	0.000536	CcSEcCtD
Felbamate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000259	0.000536	CcSEcCtD
Felbamate—Tachycardia—Estradiol—osteoporosis	0.000256	0.000529	CcSEcCtD
Felbamate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000255	0.000528	CcSEcCtD
Felbamate—Diarrhoea—Pamidronate—osteoporosis	0.000255	0.000527	CcSEcCtD
Felbamate—Hyperhidrosis—Estradiol—osteoporosis	0.000253	0.000524	CcSEcCtD
Felbamate—Rash—Ethinyl Estradiol—osteoporosis	0.000253	0.000524	CcSEcCtD
Felbamate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000253	0.000524	CcSEcCtD
Felbamate—Headache—Ethinyl Estradiol—osteoporosis	0.000252	0.000521	CcSEcCtD
Felbamate—Vomiting—Risedronate—osteoporosis	0.000249	0.000515	CcSEcCtD
Felbamate—Rash—Risedronate—osteoporosis	0.000247	0.000511	CcSEcCtD
Felbamate—Dermatitis—Risedronate—osteoporosis	0.000247	0.00051	CcSEcCtD
Felbamate—Dizziness—Pamidronate—osteoporosis	0.000246	0.000509	CcSEcCtD
Felbamate—Headache—Risedronate—osteoporosis	0.000245	0.000508	CcSEcCtD
Felbamate—Asthenia—Zoledronate—osteoporosis	0.000244	0.000505	CcSEcCtD
Felbamate—Pruritus—Zoledronate—osteoporosis	0.00024	0.000498	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000239	0.000494	CcSEcCtD
Felbamate—Nausea—Ethinyl Estradiol—osteoporosis	0.000238	0.000494	CcSEcCtD
Felbamate—Insomnia—Estradiol—osteoporosis	0.000237	0.00049	CcSEcCtD
Felbamate—Vomiting—Pamidronate—osteoporosis	0.000237	0.00049	CcSEcCtD
Felbamate—Paraesthesia—Estradiol—osteoporosis	0.000235	0.000487	CcSEcCtD
Felbamate—Asthenia—Conjugated Estrogens—osteoporosis	0.000235	0.000486	CcSEcCtD
Felbamate—Rash—Pamidronate—osteoporosis	0.000235	0.000486	CcSEcCtD
Felbamate—Dermatitis—Pamidronate—osteoporosis	0.000234	0.000485	CcSEcCtD
Felbamate—Dyspnoea—Estradiol—osteoporosis	0.000234	0.000483	CcSEcCtD
Felbamate—Headache—Pamidronate—osteoporosis	0.000233	0.000483	CcSEcCtD
Felbamate—Somnolence—Estradiol—osteoporosis	0.000233	0.000482	CcSEcCtD
Felbamate—Diarrhoea—Zoledronate—osteoporosis	0.000233	0.000481	CcSEcCtD
Felbamate—Nausea—Risedronate—osteoporosis	0.000233	0.000481	CcSEcCtD
Felbamate—Pruritus—Conjugated Estrogens—osteoporosis	0.000232	0.000479	CcSEcCtD
Felbamate—Dyspepsia—Estradiol—osteoporosis	0.000231	0.000477	CcSEcCtD
Felbamate—Decreased appetite—Estradiol—osteoporosis	0.000228	0.000471	CcSEcCtD
Felbamate—Fatigue—Estradiol—osteoporosis	0.000226	0.000468	CcSEcCtD
Felbamate—Dizziness—Zoledronate—osteoporosis	0.000225	0.000465	CcSEcCtD
Felbamate—Constipation—Estradiol—osteoporosis	0.000224	0.000464	CcSEcCtD
Felbamate—Pain—Estradiol—osteoporosis	0.000224	0.000464	CcSEcCtD
Felbamate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000224	0.000464	CcSEcCtD
Felbamate—Nausea—Pamidronate—osteoporosis	0.000221	0.000458	CcSEcCtD
Felbamate—Dizziness—Conjugated Estrogens—osteoporosis	0.000216	0.000448	CcSEcCtD
Felbamate—Vomiting—Zoledronate—osteoporosis	0.000216	0.000447	CcSEcCtD
Felbamate—Feeling abnormal—Estradiol—osteoporosis	0.000216	0.000447	CcSEcCtD
Felbamate—Rash—Zoledronate—osteoporosis	0.000214	0.000444	CcSEcCtD
Felbamate—Gastrointestinal pain—Estradiol—osteoporosis	0.000214	0.000443	CcSEcCtD
Felbamate—Dermatitis—Zoledronate—osteoporosis	0.000214	0.000443	CcSEcCtD
Felbamate—Headache—Zoledronate—osteoporosis	0.000213	0.000441	CcSEcCtD
Felbamate—Vomiting—Conjugated Estrogens—osteoporosis	0.000208	0.000431	CcSEcCtD
Felbamate—Urticaria—Estradiol—osteoporosis	0.000208	0.000431	CcSEcCtD
Felbamate—Abdominal pain—Estradiol—osteoporosis	0.000207	0.000429	CcSEcCtD
Felbamate—Body temperature increased—Estradiol—osteoporosis	0.000207	0.000429	CcSEcCtD
Felbamate—Rash—Conjugated Estrogens—osteoporosis	0.000206	0.000427	CcSEcCtD
Felbamate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000206	0.000427	CcSEcCtD
Felbamate—Headache—Conjugated Estrogens—osteoporosis	0.000205	0.000424	CcSEcCtD
Felbamate—Nausea—Zoledronate—osteoporosis	0.000202	0.000418	CcSEcCtD
Felbamate—Nausea—Conjugated Estrogens—osteoporosis	0.000194	0.000402	CcSEcCtD
Felbamate—GRIN2A—Reelin signaling pathway—RAP1A—osteoporosis	0.000192	0.0762	CbGpPWpGaD
Felbamate—Asthenia—Estradiol—osteoporosis	0.000188	0.000389	CcSEcCtD
Felbamate—Pruritus—Estradiol—osteoporosis	0.000185	0.000384	CcSEcCtD
Felbamate—Diarrhoea—Estradiol—osteoporosis	0.000179	0.000371	CcSEcCtD
Felbamate—Dizziness—Estradiol—osteoporosis	0.000173	0.000359	CcSEcCtD
Felbamate—Vomiting—Estradiol—osteoporosis	0.000167	0.000345	CcSEcCtD
Felbamate—Rash—Estradiol—osteoporosis	0.000165	0.000342	CcSEcCtD
Felbamate—Dermatitis—Estradiol—osteoporosis	0.000165	0.000342	CcSEcCtD
Felbamate—Headache—Estradiol—osteoporosis	0.000164	0.00034	CcSEcCtD
Felbamate—GRIN2B—Reelin signaling pathway—RAP1A—osteoporosis	0.000163	0.0648	CbGpPWpGaD
Felbamate—Nausea—Estradiol—osteoporosis	0.000156	0.000322	CcSEcCtD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000154	0.0613	CbGpPWpGaD
Felbamate—GRIN2B—EPHB-mediated forward signaling—ACTG1—osteoporosis	0.000144	0.0571	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—GAPDH—osteoporosis	8.59e-05	0.0341	CbGpPWpGaD
Felbamate—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—osteoporosis	7.6e-05	0.0302	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—ACTG1—osteoporosis	7.41e-05	0.0294	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—GAPDH—osteoporosis	7.3e-05	0.029	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—CAP1—osteoporosis	4.46e-05	0.0177	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—RAP1A—osteoporosis	4.4e-05	0.0175	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—ALPL—osteoporosis	4.23e-05	0.0168	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	4.22e-05	0.0168	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	4.16e-05	0.0165	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—BMP2—osteoporosis	3.71e-05	0.0147	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	3.42e-05	0.0136	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	3.26e-05	0.0129	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	3.21e-05	0.0128	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CAP1—osteoporosis	3.18e-05	0.0126	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.05e-05	0.0121	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	2.8e-05	0.0111	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—TLN1—osteoporosis	2.79e-05	0.0111	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ACTG1—osteoporosis	2.75e-05	0.0109	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CYP19A1—osteoporosis	2.74e-05	0.0109	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	2.64e-05	0.0105	CbGpPWpGaD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	2.47e-05	0.00979	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—IL1B—osteoporosis	2.41e-05	0.00957	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	2.38e-05	0.00944	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—SPP1—osteoporosis	2.25e-05	0.00893	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.22e-05	0.0088	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.19e-05	0.00869	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—ADCY5—osteoporosis	2.1e-05	0.00834	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—IL1B—osteoporosis	2.05e-05	0.00814	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—IRS2—osteoporosis	2.03e-05	0.00807	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TLN1—osteoporosis	1.99e-05	0.00791	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ACTG1—osteoporosis	1.96e-05	0.0078	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.96e-05	0.00777	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.93e-05	0.00767	CbGpPWpGaD
Felbamate—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.84e-05	0.00732	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP27A1—osteoporosis	1.82e-05	0.00721	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.8e-05	0.00713	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP27A1—osteoporosis	1.79e-05	0.00712	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.79e-05	0.00709	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—IRS1—osteoporosis	1.77e-05	0.00705	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TNF—osteoporosis	1.75e-05	0.00695	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.71e-05	0.00679	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.69e-05	0.0067	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	1.61e-05	0.0064	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—ADCY5—osteoporosis	1.61e-05	0.00639	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.59e-05	0.0063	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—WNT1—osteoporosis	1.53e-05	0.00608	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TNF—osteoporosis	1.49e-05	0.00591	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.42e-05	0.00562	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	1.4e-05	0.00557	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.39e-05	0.0055	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	1.38e-05	0.00549	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—ADCY5—osteoporosis	1.37e-05	0.00544	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.33e-05	0.00529	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.27e-05	0.00505	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.08e-05	0.00429	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.03e-05	0.00408	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.03e-05	0.00408	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.01e-05	0.00403	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	9.54e-06	0.00379	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	9.41e-06	0.00374	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.37e-06	0.00372	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.89e-06	0.00353	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6R—osteoporosis	8.71e-06	0.00346	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.43e-06	0.00335	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.34e-06	0.00331	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.33e-06	0.00331	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.31e-06	0.0033	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—LEP—osteoporosis	7.42e-06	0.00295	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	7.36e-06	0.00292	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	7.26e-06	0.00288	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.91e-06	0.00274	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.73e-06	0.00267	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6R—osteoporosis	6.22e-06	0.00247	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.18e-06	0.00245	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—POMC—osteoporosis	5.74e-06	0.00228	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—FDPS—osteoporosis	5.41e-06	0.00215	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PKM—osteoporosis	5.41e-06	0.00215	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.38e-06	0.00214	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PGLS—osteoporosis	5.13e-06	0.00204	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GPD2—osteoporosis	5.13e-06	0.00204	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.01e-06	0.00199	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ATIC—osteoporosis	4.69e-06	0.00186	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PNP—osteoporosis	4.69e-06	0.00186	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.58e-06	0.00182	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.43e-06	0.00176	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—POMC—osteoporosis	4.43e-06	0.00176	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.37e-06	0.00173	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PKM—osteoporosis	4.17e-06	0.00166	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FDPS—osteoporosis	4.17e-06	0.00166	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—OXCT1—osteoporosis	3.99e-06	0.00158	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CA2—osteoporosis	3.99e-06	0.00158	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PGLS—osteoporosis	3.96e-06	0.00157	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GPD2—osteoporosis	3.96e-06	0.00157	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MGLL—osteoporosis	3.89e-06	0.00154	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—osteoporosis	3.88e-06	0.00154	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TGFB1—osteoporosis	3.68e-06	0.00146	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PNP—osteoporosis	3.62e-06	0.00144	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ATIC—osteoporosis	3.62e-06	0.00144	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—osteoporosis	3.43e-06	0.00136	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—IDH2—osteoporosis	3.3e-06	0.00131	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP27A1—osteoporosis	3.11e-06	0.00123	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CA2—osteoporosis	3.08e-06	0.00122	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—OXCT1—osteoporosis	3.08e-06	0.00122	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ACP5—osteoporosis	3.02e-06	0.0012	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MGLL—osteoporosis	3e-06	0.00119	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.83e-06	0.00112	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TPI1—osteoporosis	2.81e-06	0.00112	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—osteoporosis	2.77e-06	0.0011	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—POMC—osteoporosis	2.66e-06	0.00106	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—P4HB—osteoporosis	2.64e-06	0.00105	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GAPDH—osteoporosis	2.59e-06	0.00103	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—IDH2—osteoporosis	2.55e-06	0.00101	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RAP1A—osteoporosis	2.53e-06	0.001	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PKM—osteoporosis	2.51e-06	0.000997	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—FDPS—osteoporosis	2.51e-06	0.000997	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.4e-06	0.000952	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PGLS—osteoporosis	2.38e-06	0.000945	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GPD2—osteoporosis	2.38e-06	0.000945	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACP5—osteoporosis	2.33e-06	0.000926	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.3e-06	0.000914	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PNP—osteoporosis	2.18e-06	0.000864	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ATIC—osteoporosis	2.18e-06	0.000864	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TPI1—osteoporosis	2.17e-06	0.000861	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ENO1—osteoporosis	2.04e-06	0.000811	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—P4HB—osteoporosis	2.04e-06	0.000809	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PSMA2—osteoporosis	2.01e-06	0.000799	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PSMA5—osteoporosis	2.01e-06	0.000799	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GAPDH—osteoporosis	2e-06	0.000794	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RAP1A—osteoporosis	1.95e-06	0.000774	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—OXCT1—osteoporosis	1.85e-06	0.000735	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CA2—osteoporosis	1.85e-06	0.000735	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MGLL—osteoporosis	1.8e-06	0.000716	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.7e-06	0.000675	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.63e-06	0.000648	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ENO1—osteoporosis	1.58e-06	0.000626	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PSMA2—osteoporosis	1.55e-06	0.000616	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PSMA5—osteoporosis	1.55e-06	0.000616	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—IDH2—osteoporosis	1.53e-06	0.000609	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.44e-06	0.000572	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACP5—osteoporosis	1.4e-06	0.000557	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ADCY5—osteoporosis	1.33e-06	0.00053	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GPX1—osteoporosis	1.33e-06	0.000528	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TPI1—osteoporosis	1.3e-06	0.000518	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.26e-06	0.0005	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTHFR—osteoporosis	1.23e-06	0.000487	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—P4HB—osteoporosis	1.23e-06	0.000487	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GAPDH—osteoporosis	1.2e-06	0.000478	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RAP1A—osteoporosis	1.17e-06	0.000465	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ADCY5—osteoporosis	1.03e-06	0.000409	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GPX1—osteoporosis	1.03e-06	0.000407	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—POMC—osteoporosis	9.81e-07	0.00039	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ENO1—osteoporosis	9.47e-07	0.000376	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTHFR—osteoporosis	9.46e-07	0.000376	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSMA2—osteoporosis	9.33e-07	0.000371	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSMA5—osteoporosis	9.33e-07	0.000371	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.57e-07	0.000301	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—POMC—osteoporosis	7.57e-07	0.000301	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ADCY5—osteoporosis	6.19e-07	0.000246	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GPX1—osteoporosis	6.17e-07	0.000245	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTHFR—osteoporosis	5.69e-07	0.000226	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—POMC—osteoporosis	4.55e-07	0.000181	CbGpPWpGaD
